Jeremy leads a global team of risk management and safety science leaders responsible for insights, evidence generation, and risk minimization efforts ensuring the safety of patients worldwide.  Jeremy is also active within numerous cross-industry pharmacovigilance initiatives for DIA, TransCelerate, and ICH. Jeremy has over 20 years of experience in development and patient safety roles and as a statistician in early phase to post-market pharmaceutical, biological, and medical device research. He holds MS and PhD degrees in quantitative psychology from Ohio University.